Intended for healthcare professionals

Letters Cancer drugs, survival, and ethics

Author’s reply to Dangoor and colleagues

BMJ 2016; 355 doi: (Published 05 December 2016) Cite this as: BMJ 2016;355:i6508
  1. Peter H Wise, physician (retired) and medical ethicist
  1. Charing Cross Hospital and Imperial College School of Medicine, London, UK
  1. wisepeter{at}

Dangoor and colleagues make some good points.1 2 My sources are indeed from different health systems—The BMJ is an international journal. I took care to validate all relevant material without prejudice, but I am happy to debate the validity of data from other sources.

Conflicts of interest are ethically important—above all in human, but also in …

View Full Text

Log in

Log in through your institution


* For online subscription